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Abstract
Nipah virus (NiV) P gene encodes P protein and three accessory proteins (V, C and W). It has been reported that all four P
gene products have IFN antagonist activity when the proteins were transiently expressed. However, the role of those
accessory proteins in natural infection with NiV remains unknown. We generated recombinant NiVs lacking V, C or W
protein, rNiV(V2), rNiV(C2), and rNiV(W2), respectively, to analyze the functions of these proteins in infected cells and the
implications in in vivo pathogenicity. All the recombinants grew well in cell culture, although the maximum titers of
rNiV(V2) and rNiV(C2) were lower than the other recombinants. The rNiV(V2), rNiV(C2) and rNiV(W2) suppressed the IFN
response as well as the parental rNiV, thereby indicating that the lack of each accessory protein does not significantly affect
the inhibition of IFN signaling in infected cells. In experimentally infected golden hamsters, rNiV(V2) and rNiV(C2) but not
the rNiV(W2) virus showed a significant reduction in virulence. These results suggest that V and C proteins play key roles in
NiV pathogenicity, and the roles are independent of their IFN-antagonist activity. This is the first report that identifies the
molecular determinants of NiV in pathogenicity in vivo.
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Introduction
Nipah virus (NiV) was first isolated in 1999 and was identified as
the etiological agent responsible for an outbreak of fatal viral
encephalitis in Malaysia and Singapore. During the first NiV
outbreak, the virus infected both pigs and humans, in addition to a
small number of cats, dogs and horses [1,2]. NiV causes severe
encephalitis with high fatality rates in humans and the virus has
been responsible for highly infectious respiratory disease with low
mortality in pigs. NiV has continued to re-emerge in Bangladesh
and India and person-to-person transmission appeared to be the
source of the outbreak in Bangladesh [3,4,5,6]. Mortality rates
recorded in outbreaks in Bangladesh reached 75%, which were
significantly higher than that observed in Malaysia [7]. However,
the molecular determinants of NiV in regard to severity of patho-
genicity and ability to cross species barriers are not yet known, and
thus remain important and urgent issues that need to be elucidated
for understanding the disease and for development of effective
vaccines. To address these issues, we have developed reverse
genetics for NiV and a NiV recombinant expressing GFP [8]. Our
study indicated that the receptor was important but was not the
sole determinant of virus permissibility in cells.
NiV, a member of the family Paramyxoviridae, possesses a
negative-sense, non-segmented RNA genome that is 18246 nt
(Malaysian isolate) or 18252 nt (Bangladesh isolate) in length [9].
It has six transcription units that encode six structural proteins, the
nucleocapsid (N), phosphoprotein (P), matrix protein (M), fusion
protein (F), glycoprotein (G) and polymerase (L). Similar to other
paramyxoviruses, the P gene of NiV expresses four proteins,
namely P, V, W and C [10,11]. V and W proteins are translated
from the edited mRNA in which one or two non-templated G
residues are inserted to the editing site during viral transcription by
the polymerase protein [10]. C protein is encoded by an alternate
open reading frame in the 59 end of the P gene, and it does not
have any amino acid identity with the P protein.
Viruses are subjected to various antiviral host responses upon
infection, and among them, interferon (IFN) responses play
important roles in early innate immunity and in the modulation
of subsequent acquired immunity [12,13]. Type I IFNs mediate
their biological functions by binding to the receptor on the target
cells, resulting in autophosphorylation and activation of the Janus
kinases (JAKs), JAK1 and tyrosine kinase 2, leading to phosphor-
ylation of the signaling molecules STAT1 and STAT2 [14,15].
The phosphorylated STATs are associated with interferon
regulatory factor 9 (IRF-9), and form an interferon-stimulated
gene factor 3 (ISGF3) [16,17], which activates the transcription of
a large number of genes involved in the establishment of virus-
resistance in the cell [18]. The V and/or C proteins of various
paramyxoviruses have been shown to have IFN-antagonist
activity. In NiV, all four of the P gene products have been
demonstrated to have IFN antagonist activity [19,20,21]. The V
and W proteins act on the IFN signaling by interacting with
PLoS ONE | www.plosone.org 1 September 2010 | Volume 5 | Issue 9 | e12709STAT1 and STAT2 [20,21,22], and the W protein also inhibits
TLR3 pathway [23]. It has been suggested that the C protein has
partial IFN antagonist activity, although the target is unclear. In
many cases, viral IFN antagonist proteins have been identified as
the important virulence factors [17,24,25,26,27,28,29]. Therefore,
studies on the function of such accessory proteins of NiV should
provide important insights into the pathogenesis and invaluable
information for vaccine design.
We investigated the role of the accessory proteins in the NiV
pathogenicity in vivo, using recombinant viruses lacking the
accessory proteins which were constructed by reverse genetics.
The results revealed that V and C proteins play key roles in NiV
pathogenicity in vivo.
Results
Effect of Nipah accessory proteins on IFN signaling
The abilities of the V, W and C proteins of NiV to inhibit IFN
signaling were analyzed by measuring the expression of the IFN-
responsive reporter gene (Fig. 1). In control cells transfected with
an empty vector, addition of 1 000 IU IFN-a resulted in the 9.5-
fold increase of luciferase activity under the control of IFN-
stimulated response element (ISRE). Transfection of expression
plasmids possessing the P, V or W ORF blocked the expression of
the ISRE reporter gene almost completely in response to IFN.
Luciferase activity was also inhibited when the C protein
expression plasmid was transfected, although the inhibition level
was lower than that observed with the other constructs. These
results were consistent with those reported previously [19,20,22].
Generation of recombinant viruses lacking V, W or
C protein
To examine the role of the NiV accessory proteins, we
constructed the recombinant infectious clones, namely pNiV(V2),
pNiV(W2) and pNiV(C2), that do not express mRNA of each
accessory protein, using our previously constructed full-length
NiV cDNA [8]. We first constructed altered P genes that do not
express V, W or C protein using a subgenomic fragment which
encompasses nucleotides 1712,4543 (the numbers refer to the
positive-sense antigenome). To prevent the expression of full-
length V or W protein, a terminator codon was introduced
immediately downstream of each RNA editing site by single
nucleotide substitution. To prevent the expression of C protein, we
introduced a terminator codon just downstream of its initiation
codon by single nucleotide substitution (Fig. 2A). These substitu-
tions were silent for the other proteins. The altered subgenomic
fragment was inserted into the full-length NiV cDNA construct via
unique FseI and PmeI restriction sites. All of the recombinant
viruses were successfully rescued using the reverse genetics, and
designated as rNiV(V2), rNiV(W2) and rNiV(C2). The sub-
stitution of the P gene in the rescued viruses was confirmed by
sequencing the reverse transcriptase-polymerase chain reaction
(RT-PCR) products.
To confirm that the V, W or C proteins was silenced properly in
the recombinant viruses, Vero cells were infected with the parental
rNiV, rNiV(V2), rNiV(W2) or rNiV(C2), and the total cell
lysates extracted from the cells were subjected to Western blotting
using rabbit anti-V, W and C antibodies. As shown in Fig. 2B, full-
length V, W or C proteins were not observed in the cells infected
with the rNiV(V2), rNiV(W2) or rNiV(C2), respectively,
although the other untargeted accessory proteins were properly
expressed at the same extent as those in the cells infected with the
parental rNiV.
In vitro growth characteristics of recombinant viruses
The in vitro growth characteristics of the recombinant viruses in
Vero and 293 cells were compared to those of the parental rNiV
(Fig. 3). All recombinants grew well ($10
5TCID50/ml) in cell
culture. However, in Vero cells, the single-step growth curve of
rNiV(V2) and rNiV(C2) indicated that the viruses had lower
growth rates and maximum titers than rNiV and rNiV(W2). In
293 cells, rNiV(V2) had a similar growth rate with the parental
rNiV, although rNiV(C2) grew to lower titers.
Inhibition of IFN-a-mediated activation of an IFN
responsive promoter
The V and W proteins of NiV have been reported to inhibit the
IFN signaling pathway, and C protein also has a weak inhibitory
effect on IFN signaling [19,20,30]. We confirmed the inhibition
effects on IFN signaling of the transfected proteins in our assay
system (Fig. 1). As our generated recombinant viruses lacked each
protein, rNiV(V2), rNiV(W2) and rNiV(C2), the viruses allowed
us to examine whether the accessory proteins really functioned as
antagonists of IFN signaling in infected cells. Reporter gene assays
have shown that the parental rNiV completely blocked ISRE
reporter gene expression, which was induced by IFN-a in infected
Vero cells (Fig. 4, +/rNiV). rNiV(W2) induced suppression of the
luciferase activity as strongly as the parental rNiV (+/W2).
rNiV(V2) also showed strong suppressive effect on the luciferase
activity. The luciferase activity in the cells infected with rNiV(C2)
was also inhibited in the absence of C protein. The result indicated
that NiV infection caused the suppression of IFN signaling, and
that the depletion of any of the accessory proteins in the infected
cells did not have influence on the suppressive effects. P protein is
essential for viral gene transcription, translation and viral
replication, and was abundantly expressed in cells infected with
each recombinant virus. As shown in Fig. 1, P protein showed a
strong suppressive effect on IFN signaling in the protein-expressed
cells. Thus, P protein is sufficient for the suppressive effect on IFN
Figure 1. Nipah P, V, W and C proteins inhibit IFN-signaling. 293
cells were transfected with pISRE-luc, an internal control vector pRL-
CMV and the indicated expression constructs (P, V, W or C) or empty
vector (ctrl). At 36 h post transfection, the medium was changed to one
containing 1 000 IU/ml of IFN-a. Luciferase assay was performed after
8 h incubation. All data were normalized by the expression level of
Renilla luciferase, and the relative luciferase activity of the IFN-a treated
(right shaded column) and untreated (left open column) cells is shown.
The numbers at the top of the columns indicate the fold increase of
luciferase activity upon IFN-a treatment. Error bars indicate the means
6 the SD of three experiments.
doi:10.1371/journal.pone.0012709.g001
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previously reported that the common amino-terminal domain of
NiV P, V and W was able to block IFN signaling pathways in cells
expressed the domain transiently. Because both rNiV(V2) and
rNiV(W2) used in this study maintained the common region
upstream of the editing site, it was considered that the N-terminal
part of P/V/W proteins, along with P protein, were sufficient to
show a strong inhibitory effect on the IFN signaling pathway in
NiV-infected cells.
Pathogenicity of the recombinant viruses
Golden hamster (Mesocritius auratus) is considered to be suitable
small animal model of NiV infection [8,31]: intra-peritoneal
inoculation of golden hamsters with NiV results in the develop-
ment of fatal nervous signs, We compared the in vivo virulence of
the three recombinants in the golden hamster model. Eight-week-
old animals (6 per group) were inoculated with rNiV(V2),
rNiV(W2) or rNiV(C2) in 10-fold dilutions (Fig. 5). rNiV(W2)
induced neurological symptoms and death at similar rate to the
hamsters inoculated with the parental rNiV (data in ref. 48). A
total of 80% of the hamsters were killed by the rNiV(W2)
infection with more than 10 000 pfu. A 50% lethal dose for
rNiV(W2) observed until 12 dpi was 3.8610
1 pfu, which was
almost the same as that for parental wt NiV (2.2610
1 pfu) [8].
Thus, rNiV(W2) was considered as virulent as rNiV. To confirm
that the mutation made for depleting W protein expression was
not reverted, we isolated viral genome from tissues of the infected
animals, and sequenced them. The introduced mutation was
retained, and thus rNiV(W2) was not reverted in the infected
animals. In contrast to the result obtained for rNiV(W2),
depletion of V or C protein dramatically reduced virulence.
rNiV(V2) and rNiV(C2) induced no clinical symptoms in
hamsters, and all hamsters survived, even with inoculations up
to 100 000 pfu of each recombinant virus. The result clearly
showed that V and C proteins play key roles in the virulence of
Nipah virus while W protein does not. We analyzed an antibody
response to NiV in sera from hamsters inoculated with greater
than 100 pfu of the each recombinant virus at 30 dpi by ELISA,
and observed the increased response (more than 1:2000 dilutions)
in all the infected animals (data not shown). Furthermore, we
performed another infection experiment with 10
3TCID50 of those
three viruses to examine whether the viruses grew in tissues of the
infected animals. The samples were taken from lung, spleen,
kidney, liver, brain and heart at 6 dpi and the viral genome in the
organs was detected by RT-PCR and quantified by real-time PCR.
As shown in Table 1, NiV genome was detected in all collected
organs of the hamsters inoculated with rNiV or rNiV(W2). The
amounts of NiV genome in organs were lower in the hamsters
inoculated with rNiV(W2) than in those inoculated with parental
rNiV at 6 dpi. Thus, it was suggested that the rNiV(W2) grew a
little slower than rNiV, and would reach to the peak after 7 dpi. In
the hamsters inoculated with rNiV(V2), virus genome was not
detected in any organs tested. However, the antibody response was
observed in all the infected hamsters, proving that rNiV(V2) have
replicated elsewhere even though at very low level. In the hamsters
inoculated with rNiV(C2), the viral genome was detected in lung,
spleen, kidney and liver though the numerical value was smaller
than those of rNiV(W2). These data suggested that rNiV(V2)a n d
rNiV(C2) replicated in the hamsters, but the growth of the viruses
remained below the threshold levels to induce clinical symptoms in
hamsters. In addition, lung appeared to be a site of extensive virus
replication.
Histopathologically, large and severe inflammatory lesions were
observed in lung collected from rNiV(W2) infected hamsters at
Figure 2. Generation of recombinant NiVs. (A) A single nucleotide change introduced into P gene ORF to produce recombinant NiVs lacking V,
W or C protein. (B) Immunoblot analysis of the V, W and C proteins expressed in Vero cells infected with the parental rNiV, rNiV(V2), rNiV(W2) and
rNiV(C2) (WT, V2,W 2, and C2, respectively). Uninfected Vero cells (mock:M) were used as controls. Arrows indicate V (left panel), W (middle panel)
or C (right panel) protein.
doi:10.1371/journal.pone.0012709.g002
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These observations were similar to the previous findings in the
hamsters infected with wild type NiV [31]. In contrast, the lungs of
rNiV(V2) infected hamsters were normal in every aspect. In lung
of rNiV(C2) infected hamsters, infiltration of inflammatory cells
were observed to a slight degree.
Discussion
Non-structural proteins of a large number of viruses are known
to have inhibitory effects on IFN signaling. In the case of NiV,
V proteins have been demonstrated to subvert IFN responses
by sequestering STAT1 and STAT2 in high molecular mass
cytoplasmic complexes without inducing degradation and the
complex formation prevents IFN-induced STAT tyrosine phos-
phorylation [20,30]. The N terminal domain of the V protein,
from residues 100 to 160, is responsible for the activity and the
region is shared by the W and P proteins [20,21,30]. Furthermore,
the single amino acid at residue 125 plays a critical role in IFN
antagonism exerted by NiV V protein [32]. The NiV W protein
has a nuclear localization signal in its unique terminal domain and
sequesters STAT1 in the nucleus, thus creating both a cytoplasmic
and a nuclear block for STAT1, and it inhibits the transcription of
Figure 4. NiV inhibits the induction of luciferase expression
from IFN responsive promoter. Vero cells were transfected with
luciferase reporter plasmids under the control of the IFN-a promoter
(pISRE-luc) and after 48 h, the cells were infected with rNiV, rNiV(V2),
rNiV(W2) or rNiV(C2). At 24 h post infection, cells were treated with
1000 U of IFN-a for 24 h, lysed, and the luciferase activities were
measured. Error bars indicate means 6 SD of the three experiments.
doi:10.1371/journal.pone.0012709.g004
Figure 5. Survival curves of the hamsters infected with different
quantities of the recombinant viruses. Hamsters (6 groups) were
inoculated intraperitoneally with 10-fold serial dilutions of either NiV or
rNiVs andsurvival rate of each groupwas observed for 30 days. (A)shows
survival curves of hamsters infected with rNiV(W2) and (B) shows that of
hamsters infected with rNiV(V2) and rNiV(C2).
doi:10.1371/journal.pone.0012709.g005
Figure 3. Comparison of the replication of the parent wild type
(rNiV) and of the recombinant viruses, rNiV(V2), rNiV(W2) and
rNiV(C2). Vero and 293 cells were infected with each virus at a moi of
0.01 pfu/cell for 1 h. Cell supernatants were collected at the indicated
time points for the determination of virus titer. Error bars indicate
means 6 SD from three experiments.
doi:10.1371/journal.pone.0012709.g003
Table 1. Quantification of NiV N genome in hamster tissues.
ID lung spleen kidney liver brain heart
mock 1 0.002 0.001 0.033 0.003 0.000 0.000
2 0.003 0.000 0.002 0.003 0.000 0.001
rNiV 3 1562.082 3.576 124.812 7.491 28.318 8.921
4 2237.473 12.843 79.734 35.968 71.092 65.189
rNiV(V2) 5 0.001 0.003 0.003 0.004 0.001 0.001
6 0.001 0.000 0.001 0.002 0.004 0.001
rNiV(C2)70.937 0.251 0.112 0.010 0.000 0.012
8 0.906 0.094 0.032 0.036 0.001 0.003
rNiV(W2)9186.666 8.124 41.107 2.785 2.531 8.732
10 32.053 0.361 5.521 0.281 0.078 0.129
Bold letters: NiV N detected (rounded down to second decimal place).
doi:10.1371/journal.pone.0012709.t001
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ISGF3 [21,33]. Thus, P, V and W proteins act as antagonists for
IFN-responses by sequestering STAT proteins, with the W protein
being the most efficient and the P protein the least [34]. NiV V
and W proteins can also inhibit virus-induced activation of the
IFN-b promoter and IRF3-responsive promoter (ISG54 promoter)
and only the W protein shows strong inhibition of promoter
activation in response to the stimulation of Toll-like receptor 3
[23]. NiV C protein was also suggested to have weak IFN
antagonist activity, but the target is unclear [19].
These antagonistic activities of IFN-signaling of P, V, W and C
of NiV were all demonstrated by the experiments using transiently
expressed proteins following transfection with plasmid DNA, and
we also confirmed strong inhibition of IFN response with P, V, W
and C proteins expressed by plasmids in the reporter gene assay
(Fig. 1). However, whether these proteins actually function in the
infected cells wasnot clarified.To address thisquestion,we generated
recombinant viruses lacking accessory proteins. rNiV(V2)a n d
rNiV(W2), as well as parental rNiV, induced strong suppression of
the IFN response observed by the same reporter gene assay.
Particularly, the W knockout virus rNiV(W2) showed the complete
inhibitory effect. It indicated that the domain unique to W protein
does not play a role on the suppressive effect in the infected cells, or
that the suppressive effects of the other remained proteins are
sufficient to show the complete inhibitory effects. Both recombinant
viruses used in this study expressed intact P protein and the N
terminus of V or W proteins containing the STAT-binding region,
which is upstream of the editing site. Thus, it is understandable that
our recombinant viruses that lacked full-length V or W proteins still
retained IFN antagonist activities that were comparable to rNiV.
This result is in agreement with the previous studies showing that
the N-terminal domain of these proteins transiently expressed in
cells has strong IFN-antagonist activities [35]. The C knockout virus
rNiV(C2), in which the C protein is completely removed, also
induced strong suppression of the IFN response in the infected cells.
This is not surprising because P, V, and W proteins were not
depleted from rNiV(C2). This result may concur with the previous
findings that indicated that measles virus (MV) and rinderpest virus
(RPV) C protein had no effect or had a weaker effect on IFN
signaling in the context of viral infection [13,36]. It seems likely that
the C protein may have the potential to inhibit IFN signaling, as
suggested by the results of the experiments with C protein-expressed
cells, but the effect is probably not significant in the virus infected
cells.
Previously, we reported that the rNiV induced severe
encephalitis and death in hamsters in the dose-dependent manner
similar to those induced by the parental NiV [8]. The virulence of
rNiV(W2) tested in the present study was not altered as compared
to those of rNiV and NiV, and the virus killed animals in a similar
dose-dependent manner. However, the virulence of rNiV(V2) and
rNiV(C2) were dramatically reduced and they did not kill any of
the hamsters even when the animals were inoculated with as much
as 10
5 pfu of the viruses.
Viral genome was detected in some organs collected from
rNiV(C2) infected hamsters, but not in those from rNiV(V2)
infected hamsters. Anti-NiV antibody response was induced
following infection with each of the viruses, including rNiV(V2),
indicating that rNiV(V2) replicated somewhere in the animal
body although the viral genome was not detected in tested organs
of hamsters inoculated with low titers of rNiV(V2) at 6 dpi.
Although rNiV(W2) showed severe pathogenicity and killed the
infected hamsters at similar rates compared with those with the
parental rNiV, virus growth in organs of the infected animals were
lower, or slower, than those in the rNiV infected animals. Thus, W
protein probably affects the virus growth in organs of the infected
animals, even though the effect is weaker than V and C. However,
since NiV pathogenicity is extremely strong, the lower amount of
replicated rNiV(W2) in the body seemed to be sufficient to kill the
animals. These observations clearly showed that the V and C
proteins, but not the W protein, play a significant role in NiV
pathogenicity.
It should be noted that although rNiV(V2) and rNiV(C2), in
addition to rNiV(W2), retained the strong antagonistic activities
on IFN-signaling in their infected cultured cells (Fig. 4), rNiV(V2)
and rNiV(C2) lost virulence in vivo (Fig. 5). These results suggest
that the major roles of the V and C proteins on in vivo patho-
genicity are probably not implemented through the inhibitory
activities on IFN signaling.
Figure 6. Histopathology in lungs. The thin sections of kidney samples obtained from hamsters infected with rNiV, rNiV(V2), rNiV(C2) and
rNiV(W2), were stained with hematoxylin and eosin. Severe inflammation lesions were observed in lung from rNiV or rNiV(W2) infected hamsters. In
lung of rNiV(C2) infected hamsters, mild infiltration and inflammation were observed. The lung from rNiV(V2) was normal.
doi:10.1371/journal.pone.0012709.g006
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recombinant viruses replicated efficiently in Vero and 293 cells,
although their maximum titers differed. Among the recombinant
viruses, only rNiV(W2) showed a similar growth curve to the
parental rNiV and reached the same maximum titer in both Vero
and 293 cells. Growth of rNiV(C2) was slower, and its maximum
titer was lower than that of the parental rNiV. The less efficient
growth feature of the rNiV(C2) was not related to its IFN-resistant
properties because Vero cells do not produce IFN whilst 293 cells
do. Previous studies indicated that the paramyxovirus C proteins
are multifunctional proteins. The MV C protein regulates viral
RNA synthesis [37], in addition to inhibiting the IFN response
[38]. Sendai virus C proteins were reported to be relatively
versatile and were considered to play a role in inhibiting viral
transcription and replication [39,40], and in virus assembly and
budding [35,41], in addition to the effect on IFN signaling [42,43].
The growth rate of the C knockout Sendai virus was slower than
that of the parental virus and the yield was lower [41]: it showed
reduced pathogenicity in mice in comparison to the parental virus
[44], which was similar to our observation using rNiV(C2). Thus,
the C protein of NiV might also contribute to virus assembly and
affect virus growth in certain cells. Further study is required to
clarify these issues.
The mechanism by which the deletion of the V protein of NiV
confers attenuation phenotype also remains to be elucidated.
rNiV(V2) has revealed different features of viral growth in two
kinds of cells. It grew and reached the same maximum titer as the
parental virus in 293 cells but had slower growth and lower yield
in Vero cells. This result suggests that the NiV V protein may play
an unknown role in virus replication which affects Vero cells but
not 293 cells. Several reports discuss the function of V proteins in
vivo using V-knockout paramyxoviruses. It has been reported that
the infection rate of T cells with V-knockout canine distemper
virus (CDV) was reduced and the virus failed to deplete the T-cell
fraction of peripheral blood mononuclear cells (PBMC) in ferrets
(Mustela putorius furo) [45]. This V-knockout CDV unregulated not
only IFNs but also cytokines, such as tumor necrosis factor alpha,
IL-6, IL-2 and IL-4. Similarly, in MV, the V protein was reported
to interfere with STAT3-dependent IL-6 signaling [46]. There-
fore, V protein is likely to have pleiotropic anti-immune response
functions and thus depletion of this protein may attenuate the virus
in vivo.
The effects of IFN antagonistic activities of V and W proteins on
in vivo pathogenicity could not be analyzed in our study because
the STATs-interacting domain of V/W resides in the region
shared by P protein. Since P protein is essential for viral RNA
synthesis, we were unable to delete it when generating recombi-
nant viruses. However, a recent report has revealed that Ser130
and Ser131 of the NiV P protein are responsible for binding to
STAT1 and STAT2 and normal IFN signaling interference, and
mutations introduced on these sites has no effect on its ability to
support minigenome transcription and replication [47]. Therefore,
the role of the IFN antagonistic activities of V/W proteins on
in vivo pathogenicity can now be assessed by producing recom-
binant viruses which do not inhibit STAT-dependent IFN
antiviral response.
In this study, we found that the depletion of the V or C protein
significantly reduced the pathogenicity of NiV in vivo. Such a
drastic decrease in pathogenicity has not been reported in any
members of the paramyxoviruses. On the contrary of the previous
speculation, the attenuation mechanism observed in the rNiV(V2)
and rNiV(C2) are not caused by the loss of IFN antagonist
activities due to these proteins, because rNiV(V2) and rNiV(C2)
retained similar activities in infected cells. Further studies should
clarify the unknown mechanisms and the possibility of attenuated
viruses serving as effective vaccine candidates should also be
elucidated.
Materials and Methods
Ethical treatment of animals
All animal experiments were approved by Comite ´r e ´gional
d’ethique pour l’expe ´rimentation animale Rhone Alpes.
Cells
Vero (monkey kidney), CV-1 (monkey kidney) and 293 (human
kidney) cells were maintained in Dulbecco’s modified Eagle
medium (DMEM) (GIBCO BRL) containing 5% fetal bovine
serum (FBS), L-glutamine and antibiotics.
Rescue of recombinant virus from cDNA
The plasmid pNiV(6+), containing the full-length NiV cDNA
flanked by T7 RNA polymerase sequence, has been described
previously [8]. To construct the full-length genome plasmid for the
recombinant virus-lacking C protein, the nucleotide 2444T (the
number refers to the positive-sense antigenome) was changed to
‘A’ to introduce a terminator codon. For the recombinant virus-
lacking V or W protein, a terminal codon was introduced by
substitution downstream of each editing site.
The V, W or C protein-lacking viruses designated ‘rNiV(V2)’,
‘rNiV(W2)’ and ‘rNiV(C2)’, were rescued from these cDNA in
accordance with the procedure described previously [8]. The
rescued viruses were passaged once in Vero cells and stored at
280uC.
Western blotting
Vero cells were infected with rNiV, rNiV(V2), rNiV(W2)o r
rNiV(C2) at a multiplicity of infection (moi) of 0.1. The cells were
collected at 24 hpi, and total cell lysates were extracted using
Trizol reagent (Invitrogen) in accordance with the instructions of
the manufacturer. Cellular proteins are isolated from the phenol-
ethanol supernatant obtained after ethanol precipitation of DNA.
The lysates were boiled in 26 sodium dodecyl sulphate (SDS)-
loading buffer with 5% beta-mercaptoethanol for 5 min and
separated on 14% polyacrylamide gels. Resolved proteins were
transferred to polyvinylidine difluoride membranes and blocked
overnight with 5% skimmed milk in (Tris-buffered saline Tween)
TBST (0.05% Tween 20 in TBS). Blots were incubated with
primary antibodies for 60 min at room temperature and washed
six times with TBST. The primary anti-V, W and C antibodies
were produced in rabbits by immunization of peptides which were
designed from unique regions of those proteins. Subsequently, the
blots were further incubated with the secondary horse radish
peroxidase (HRP)-conjugated anti-rabbit antibody for 30 min.
After washing, bands were visualized using the ECL
TM Western
blotting detection system (Amersham).
Virus growth
Vero and 293 cells (1610
6/6-well plate) were infected with
rNiV, rNiV(V2), rNiV(W2) or rNiV(C2) at an moi of 0.01 for
1 h. The inoculum was removed and the cells washed once with
medium and then incubated in DMEM +2% FBS. Cells and
supernatants of wells infected with these viruses were harvested
24 h, 48 h and 72 h later, centrifuged and then stored at 280uC.
The TCID50/ml of each sample was measured using standard
methods. The experiment was repeated twice.
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Golden hamster (Mesocricetus auratus) appears to be a reliable
model of NiV infection [8,31]. Eight-week-old golden hamsters
were injected intraperitoneally with recombinant NiV after being
anaethetised with isoflurane (Aerrane; Baxter S.A.). The animals
were housed in ventilated containers equipped with high efficiency
particulate air (HEPA) filters in the BSL-4 laboratory.
Real-time PCR analyses
The tissue samples, dissected from the infected hamsters, were
homogenized in 500 ml of Trizol reagent and total RNAs were
extracted in accordance with the instructions of the manufacturer.
First strand cDNA was synthesized using toal RNA and random
primer. For real time RT-PCR, total RNA was reverse-transcribed,
and then it was PCR-amplified by ABI Prism 7900HT (Applied
Biosystems, USA) using SYBR Premix Ex TaqII (Takara, Japan).
Specific HPRT (hypoxanthine-guanine phosphoribosyltransferase)
primers were used as an internal control. The data were analyzed
with Sequence Detection Systems ver 1.7a software (Applied
Biosystems). The expression levels of the target genes were
calculated using the threshold cycle time (Ct), the first cycle number
at which emitted fluorescence exceeds 106the standard deviation
(SD) of base-line emission as measured in the cycles of PCR.
Standard curve was generated using known cDNA concentration
(10-fold dilution from 10 ng ,1 pg/reaction). Normalized results
were expressed as the ratio pg RNA of NiV N gene to pg RNA of
the HPRT gene.
Reporter gene assays
The sequences coding for P, V, W and C proteins were
amplified by PCR with primers containing SalI sites at both ends
of the fragment using Thermo-Start DNA polymerase (AB gene).
The PCR products were digested by SalI and cloned into pCMV-
myc vector (BD bioscince). For luciferase assays, Vero cells were
transfected with three plasmids, namely: pCMV-myc construct of
each of the relevant genes or a pCMV-myc empty vector as a
control, a plasmid containing the luciferase gene downstream to an
IFN-stimulated response element (pISRE-luc) and a construct
encoding the Renilla luciferase protein (pRL-luc) using lipofecta-
mine LTX (Invitrogen). To assay virus-infected cells, Vero cells
were transfected with pISRE-luc and pRL-luc two days prior to
infection; the recombinant viruses were then infected at a moi of 2.
On the following day, the medium was replaced with medium
containing 1 000 IU of IFN-a, and incubation was continued for
24 h. The cells were harvested to analyze luciferase activity.
Luciferase assays were performed using the Renilla luciferase assay
system (Promega) in accordance with the instructions of the
manufacturer.
Histopathological examination
Organs removed at autopsy were fixed in 10% formalin,
dehydrated and embedded in paraffin using routine techniques.
Thin sections were stained using hematoxylin and eosin.
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